Allergan
Almirall picks up Allergan’s dermatology portfolio to for $650m
August 3, 2018Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma
Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …
Allergan sues Pfizer over opioid crisis lawsuits
August 3, 2018Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids
Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …
US court overturns Allergan’s controversial attempts to avoid Restasis patent review
July 23, 2018Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma
The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
Allergan appoints ex-Abbott exec in “Board refreshment” move
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma
Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
Allergan’s atogepant fulfils primary endpoint in episodic migraine
June 12, 2018Manufacturing and Production, Research and Development Allergan, atogepant, migraine, pharma
Allergan has made ground in its quest to become “the headache company” with the release of new Phase 2b/3 data …
Allergan mauled by investors in public letter
June 6, 2018Medical Communications, Research and Development Allergan
Last week, Allergan announced that a strategic review of its operations had led to a decision to divest its women’s …
Axovant snatches Teva and Allergan execs to strengthen management
June 5, 2018Manufacturing and Production, Medical Communications Allergan, Axovant, Teva, appointment, pharma
Axovant has announced reinforcements to its management team with two new additions, snatching up Allergan’s current Chief Medical Officer Dr …
Top Ten most popular articles on Pharmafile.com this week
June 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, AstraZeneca, Cancer, Gilead, HIV, J&J, JJ, google, machine learning, melanoma, pharma, top ten
The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …
Allergan aims to appease investors with non-core units sell off
May 31, 2018Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical
Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …
Allergan recalls 170,000 birth control packs in US over pregnancy fears
May 30, 2018Research and Development Allergan, FDA, Taytulla, US, birth control, pharma
Allergan has issued a voluntary recall of its birth control medication in the US marketplace after an error in packaging …
Amgen/Novartis potential blockbuster migraine med gets FDA nod
May 18, 2018Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …
Allergan unveils second bout of Phase 3 success in migraine
April 30, 2018Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant
Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …
Allergan out but Takeda sticks to guns on Shire
April 20, 2018Medical Communications, Sales and Marketing Allergan, Shire, Takeda, biotech, drugs, pharma, pharmaceutical
Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …
Top Ten most popular articles on Pharmafile.com this week
April 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
Rumours Allergan is looking to offload $5bn women’s health unit
April 3, 2018Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical
According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
Latest content
FibroFind appoints Lee Borthwick as CEO
